Your session is about to expire
← Back to Search
Radiation Therapy
FLASH Radiotherapy for Bone Metastasis (FAST-01 Trial)
N/A
Waitlist Available
Led By John Breneman, MD
Research Sponsored by Varian Medical
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessed at day 15, months 1, 2, 3, long term; flare in bone pain assessed during the first 10 days after treatment
Awards & highlights
FAST-01 Trial Summary
This trial will test if FLASH radiotherapy can provide pain relief for people with bone metastases.
Eligible Conditions
- Bone Metastasis
FAST-01 Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ will be assessed within 4 weeks of subject enrollment.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~will be assessed within 4 weeks of subject enrollment.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Assessment of radiation-related toxicities that are possibly, probably, or definitely related to FLASH radiotherapy.
Workflow feasibility
Secondary outcome measures
Pain relief
Use of pain medication.
FAST-01 Trial Design
1Treatment groups
Experimental Treatment
Group I: FLASH radiotherapy for painful bone metastasis(-es)Experimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
FLASH Radiotherapy
2020
N/A
~10
Find a Location
Who is running the clinical trial?
Varian MedicalLead Sponsor
6 Previous Clinical Trials
320 Total Patients Enrolled
Varian, a Siemens Healthineers CompanyLead Sponsor
30 Previous Clinical Trials
7,263 Total Patients Enrolled
John Breneman, MDPrincipal InvestigatorProfessor of Radiation Oncology and Neurosurgery, UCMC
1 Previous Clinical Trials
10 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger